Searchable abstracts of presentations at key conferences in endocrinology

ea0054p2 | (1) | NuclearReceptors2018

Next generation glucocorticoid receptor modulators

Edman Karl , Belfield Graham , Dearman Matthew , Edenro Goran , Geschwindner Stefan , Hegelund-Myrback Tove , Hemmerling Martin , Hendrickx Ramon , Keen Christina , Karrman-Mardh Carina , Lepisto Matti , Mitra Suman , Monkley Susan , Prothon Susanne , Ripa Lena , Steele John , Vaarala Outi , Wissler Lisa , Oberg Lisa

Synthetic glucocorticoids bind to the glucocorticoid receptor (GR) and have been used for nearly 70 years to treat inflammatory diseases. However, their use is limited by adverse effects such as diabetes, muscle wasting and osteoporosis. High throughput screening identified a novel non-steroidal scaffold with great potential for chemical optimization. Through rational design we developed the indazole ether series which combines high potency with structural motifs that provide ...

ea0065p350 | Reproductive Endocrinology and Biology | SFEBES2019

Gonadotrophin rise following the kisspeptin analogue (MVT-602) is increased in women with hypothalamic amenorrhoea compared to healthy women

Eng Pei Chia , Abbara Ali , Phylactou Maria , Clarke Sophie A , Yang Lisa , Mills Edouard , Modi Manish , Papadopoulou Deborah , Plumptre Isabella , Hunjan Tia , Purugganan Kate , Webber Lisa , Salim Rehan , Comninos Alexander N , Dhillo Waljit S

Introduction: Hypothalamic amenorrhoea (HA) is a condition characterised by reduced GnRH pulsatility and is a common cause of anovulatory subfertility. Kisspeptin is an endogenous neuropeptide that regulates hypothalamic GnRH function. Hypothalamic kisspeptin expression is reduced, and kisspeptin receptor expression is increased, in a rodent model of HA. The kisspeptin analogue MVT-602 has a 3-4-fold longer half-life than native kisspeptin-54 (t1/2 0.5 h). We invest...

ea0077p138 | Adrenal and Cardiovascular | SFEBES2021

Impact of COVID-19 on patients with primary adrenal insufficiency: a cross-sectional study

Knowles Gregory , Warmington Emily , Shepherd Lisa , Hazlehurst Jonathan , Bray Anne De , Gleeson Helena , Arlt Wiebke , Prete Alessandro

Background: Primary adrenal insufficiency (PAI) predisposes patients to infections, which can precipitate life-threatening adrenal crises. PAI patients are thought to be particularly vulnerable to COVID-19; however, little is known about its true impact on this group.Aim: To assess morbidity and health promotion attitudes during the COVID-19 pandemic amongst a large cohort of PAI patients.Methods: In May 2020 COVID-19 information, ...

ea0077p132 | Nursing Practice | SFEBES2021

Systematic review of behavioural change interventions for the prevention of adrenal crisis in adults with primary adrenal insufficiency – An infographic interpretation

Shepherd Lisa , Schmidtke Kelly Ann , Hazelhurst Jonathan , Arlt Wiebke , Carrick-Sen Debbie , Dretzke Janine , Swift Amelia , Hawks Noel , Tahrani Abd

Background: The incidence of adrenal crisis remains constant, despite the introduction of behavioural interventions to educate and empower patients. To increase the success of future behaviour change interventions, theoretically informed and empirically supported behaviour change frameworks are available. The current review aimed to identify and evaluate available evidence of interventions used to prevent adrenal crisis in people with primary adrenal insufficiency to inform fu...

ea0077p133 | Nursing Practice | SFEBES2021

Development of interventions to prevent adrenal crisis – How can application of behaviour change theory and intervention frameworks inform practice?

Shepherd Lisa , Hazelhurst Jonathan , Carrick-Sen Debbie , Swift Amelia , Tahrani Abd , Dretzke Janine , Hawks Noel , Ann Schmidtke Kelly

Background: Behavioural interventions have been developed to empower patients with adrenal insufficiency and prevent adrenal crisis. Behavioural theory, such as the theoretical domains framework, can inform future intervention development. The current systematic review aims to describe what techniques have been employed in previous interventions and highlight neglected behavioural barriers that could be targeted in future interventions.Methods: We perfor...

ea0052p03 | (1) | UKINETS2017

Blood measurements of Neuroendocrine Tumor (NET) transcripts and gene cluster analysis predict efficacy of PRRT

Bodei Lisa , van der Zwaan Wouter , Kidd Mark , Drozdov Ignat , Baum Richard P , Kwekkeboom Dik , Krenning Eric , Modlin Irvin M

Background: Peptide receptor radionuclide therapy (PRRT) is based on tumor somatostatin receptor (SSR) overexpression to deliver targeted isotope therapy. Functional imaging of SSR expression (SRE) is used as a predictor of efficacy, but there is no method to objectively predict PRRT efficacy. We report the efficacy of Predictive Quotient Index (PQI) to predict the utility of PPRT. PQI is derived from circulating NET transcript analysis (NETest) integrated with the tu...

ea0086p70 | Metabolism, Obesity and Diabetes | SFEBES2022

Liver specific microparticles to improve islet transplantation outcomes in Type 1 diabetes

Walker Sophie , Lee I-ning , Gadd Victoria , Mellis David , Henderson John , Judge Amelia , Forbes Stuart , White Lisa , Forbes Shareen

Background: Islet transplant into the liver is a therapy for type 1 diabetes patients experiencing severe hypoglycaemia or impaired hypoglycaemic awareness. Widespread use is not currently considered due to the requirement for immunosuppression for the lifetime of the graft, and the attrition in graft function over the following 1-5 years. Following transplant into the liver, inflammation results in >60% islet loss, with few patients achieving insulin independence. The liv...

ea0090p693 | Pituitary and Neuroendocrinology | ECE2023

Characterizing the expression of thyroid hormone transporter MCT8 for the treatment of Allan-Herndon-Dudley syndrome

Molenaar Anna , Schriever Sonja , Cebrian Serrano Alberto , Pathak Ekta , Maity-Kumar Gandhari , Stander Lisa , Englmaier Felix , Muller Timo , Pfluger Paul

Allan-Herndon-Dudley syndrome (AHDS) is a genetic disorder characterized by intellectual disability and movement disorders. AHDS patients have mutations in the monocarboxylate transporter 8 (MCT8) that impedes thyroid hormone (TH) transport to the brain during crucial phases of brain development. In mice, the resulting structural and functional pathologies of human AHDS patients can be mimicked by knocking out murine MCT8 and the Solute Carrier Organic Anion Transporter Family...

ea0065p276 | Neuroendocrinology | SFEBES2019

The effect of tumor staining pattern on secondary hormonal deficiency in nonfunctioning pituitary adenomas

Ali Imran Syed , Almistehi Wael M , Hebb Andrea L O , Doucette Steve , Tramble Lisa , Massoud Emad , Clarke David B

Secondary hormonal deficiency (SHD) is common in patients presenting with nonfunctioning pituitary adenomas (NFA). NFA can either stain for various hormones or be non-hormone staining on immunocytochemistry. To date, no study has assessed the association between staining pattern of NFA and pattern of SHD at presentation. The Halifax Neuropituitary Program has been prospectively collecting comprehensive data on all neuropituitary patients in the province of Nova Scotia, Canada ...

ea0063gp226 | Adrenal and Neuroendocrine - Clinical (1) | ECE2019

Evaluation of the CCK-2 receptor agonist 177Lu-PP-F11N for radionuclide therapy of medullary thyroid carcinoma – final Results of the phase 0 ‘Lumed’ Study

Rottenburger Christof , Nicolas Guillaume , McDougall Lisa , Kaul Felix , Cachovan Michael , Schibli Roger , Geistlich Susanne , Behe Martin , Wild Damian , Christ Emanuel

Objectives: Despite the introduction of new molecular targeted therapies, there is still an unmet need for an effective systemic therapy for advanced medullary thyroid carcinoma (MTC). As MTC expresses cholecystokinine-2 (CCK-2) receptors at a high incidence and density, targeting the CCK-2 receptor with radiolabelled gastrin analogues is a potential approach for radionuclide therapy. Unfortunately, kidney and bone marrow toxicity precluded therapeutic applications of CCK-2 re...